During the past decade, CHU Saint-Pierre conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 34 clinical trials were completed, i.e. on average, 29.1% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 19 clinical trials were completed. i.e. 36.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Saint-Pierre" #1 sponsor was "Centre Hospitalier Universitaire Saint Pierre" with 31 trials, followed by "Gilead Sciences" with 13 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored and "Boehringer Ingelheim" with 9 trials sponsored. Other sponsors include 100 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Saint-Pierre" #1 collaborator was "Centre Hospitalier Universitaire Saint Pierre" with 5 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "Erasme University Hospital" with 4 trials as a collaborator, "Agentschap voor Innovatie door Wetenschap en Technologie" with 3 trials as a collaborator and "Guy's and St Thomas' NHS Foundation Trust" with 3 trials as a collaborator. Other collaborators include 226 different institutions and companies that were collaborators in the rest 216 trials.

According to Clinical.Site data, the most researched conditions in "CHU Saint-Pierre" are "HIV Infections" (15 trials), "Ulcerative Colitis" (9 trials), "HIV" (7 trials), "HIV-1 Infection" (6 trials) and "COVID-19" (5 trials). Many other conditions were trialed in "CHU Saint-Pierre" in a lesser frequency.

Most popular intervention types in "CHU Saint-Pierre" are "Drug" (96 trials), "Other" (32 trials), "Device" (20 trials), "Biological" (10 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "FTC/TDF" (5 trials), "ATV" (4 trials), "E/C/F/TAF" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "CHU Saint-Pierre" are 157 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 45 active trials in "CHU Saint-Pierre". 2 are not yet recruiting, 25 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 98 completed trials in CHU Saint-Pierre, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Saint-Pierre, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 37 trials that are defined as “Not Applicable".

CHU Saint-Pierre has several departments that took part in Clinical trials: "CHU St Pierre; pulmonology department" - 5 trials